Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Top drugs by sales in 2017: Who sold the blockbuster drugs?
The year 2017 was a landmark year for pharmaceutical
industries in the US and Europe, with a sharp i
Trump tells FDA to fund itself fully through industry fees; Astra’s CEO dumps Teva offer
This
week, Phispers brings you lots of regulatory news from the US, where the Trump
administration h
Top drugs by sales in 2016: Who sold the blockbuster drugs?
The year 2016 finished with a whimper insofar as mergers and acquisitions (M&As) were concerned.
Capsugel’s U.S. plant has data-integrity issues, billion dollar Chinese bid for Indian sterile manufacturer, Pfizer & Mylan’s dermatology bet
This week’s Phispers has regulatory and M&A news from across the world as Pfizer ends its
Top drugs by sales revenue in 2015: Who sold the biggest blockbuster drugs?
The year 2015 has gone down
in history as a record year for mergers and acquisitions in the pharmace
Phispers: Ranbaxy whistleblower takes Indian govt to court; Merck claims US $ 3 billion from Gilead & more
This week, Pharmaceutical
Whispers (Phispers) looks at Ranbaxy whistleblower’s public interest